HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuki Hasegawa Selected Research

Kazuki Hasegawa Research Topics

Disease

7Neoplasms (Cancer)
04/2023 - 01/2017
3Squamous Cell Carcinoma of Head and Neck
04/2023 - 12/2020
3Neoplasm Metastasis (Metastasis)
11/2022 - 03/2019
3Fibrosarcoma
01/2021 - 03/2019
2Mouth Neoplasms (Oral Cancer)
12/2020 - 06/2020
2Prostatic Neoplasms (Prostate Cancer)
06/2019 - 05/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022
1Residual Neoplasm
03/2019
1Type 2 Diabetes Mellitus (MODY)
08/2018
1Body Weight (Weight, Body)
08/2018
1Mediastinitis
05/2004
1Infections
05/2004

Drug/Important Bio-Agent (IBA)

4Hyaluronic Acid (Hyaluronan)IBA
11/2022 - 03/2019
4HymecromoneIBA
11/2022 - 03/2019
18- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
04/2023
1Radiation-Sensitizing AgentsIBA
11/2022
1Hyaluronan SynthasesIBA
11/2022
1IodineIBA
03/2022
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
03/2022
1PeplomycinIBA
12/2020
1Interleukin-1 (Interleukin 1)IBA
03/2019
12- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
08/2018
1Sitagliptin Phosphate (Januvia)FDA Link
08/2018
1Dipeptidyl-Peptidase IV InhibitorsIBA
08/2018
1Hemoglobins (Hemoglobin)IBA
08/2018
1MicroRNAs (MicroRNA)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017

Therapy/Procedure

6Radiotherapy
04/2023 - 03/2019
2Chemoradiotherapy
12/2020 - 06/2020
1X-Ray Therapy
01/2021
1Drug Therapy (Chemotherapy)
03/2019
1Debridement
05/2004